Page 30 - CIRN Annual Report 2017-18

CIRN | 2018 ANNUAL REPORT

• H Gillis. Discrimination of Vaccine-Preventable Streptococcus Pneumoniae Serotypes using PCR and
Sequencing. CIRN Annual General Meeting, Halifax, NS. May 24, 2017.

• A Lang. Validation of PCR-Based Detection and Serotype Deduction of Streptococcus Pneumoniae from
NP Swabs collected for Viral Studies in Cases of CAP. CIRN Annual General Meeting, Halifax, NS. May 24,
2017.

• A Oliver. Increasing the Diagnostic Yield of Pneumococcal Community Acquired Pneumonia in Hospitalized
Adults using Combinative Laboratory Testing. CIRN Annual General Meeting, Halifax, NS. May 24, 2017.

• J Schembri. Multitarget plasmid controls for conventional and real-time PCR-Based Serotyping of
Streptococcus Pneumoniae. CIRN Annual General Meeting, Halifax, NS. May 24, 2017.

• J Leblanc. Decrease in PCV13 serotypes in adults hospitalized with pneumococcal pneumonia over
time: evidence herd immunity eff ects from childhood vaccination. Infectious Diseases Week, Halifax, NS.
October 2017.

• Z Shaff elburg, on behalf of CIRN SOS Network Investigators. Impact of Oseltamivir in the Prevention of
Serious Outcomes Associated with Infl uenza in Hospitalized Canadian Adults: A Pooled Analysis from the
Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN).
Dalhousie Medical School Research in Medicine Day, Halifax, NS. April 8, 2017.

• R Amiro, on behalf of CIRN SOS Network Investigators. Infl uenza risk factors, outcomes, and vaccine
eff ectiveness among immunocompromised adults admitted with acute respiratory illness (ARI) from 2011/12
to 2013/14: A Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS)
Network Study. Dalhousie Medical School Research in Medicine Day, Halifax, NS. April 8, 2017.

• Z Shaff elburg, on behalf of CIRN SOS Network Investigators. Impact of Oseltamivir in the Prevention of
Serious Outcomes Associated with Infl uenza in Hospitalized Canadian Adults: A Pooled Analysis from the
Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN).
CCfV Symposium/ID Research Day, Halifax, NS. April 11, 2017.

• S Mulpuru, on behalf of all other CIRN SOS Network and TIBDN Investigators. Infl uenza Burden, Risk
Factors for Severe Disease, and Infl uenza Vaccine Eff ectiveness among Patients with Chronic Obstructive
Pulmonary Disease (COPD) Admitted to Hospital with Lab-confi rmed Infl uenza: A Study from the Serious
Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN). CCfV
Symposium/ID Research Day, Halifax, NS. April 11, 2017.

• M Nichols on behalf of all other CIRN SOS Network Investigators. Impact of Prior Season Vaccination
on Seasonal Infl uenza Vaccine Eff ectiveness: A preliminary analysis over 4 seasons from the CIRN SOS
Network. CCfV Symposium/ID Research Day, Halifax, NS. April 11, 2017.

• SA McNeil, on behalf of all other CIRN SOS Network and TIBDN Investigators. Vaccine Eff ectiveness (VE) of
non-adjuvanted and adjuvanted trivalent inactivated infl uenza vaccines (TIV) in the prevention of infl uenza-
related hospitalization in Canadian seniors over the 2011/12 through 2013/14 season: A pooled analysis
from the Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network
(CIRN). CCfV Symposium/ID Research Day, Halifax, NS. April 11, 2017.